PRDX2, peroxiredoxin 2, 7001

N. diseases: 243; N. variants: 2
Disease: Esophageal Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms 		0.330 Biomarker group BEFREE The expression levels of ZNF667-AS1 and ZNF667 were significantly reversed by treatment with 5-Aza-dC and TSA in esophageal cancer cell lines. 31804468 2019
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms 		0.330 AlteredExpression group BEFREE The expression level of CTC-276P9.1 in esophageal cancer cells was significantly reversed by treatment with 5-Aza-dC and TSA. 29524086 2018
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms 		0.330 Biomarker group BEFREE We reported 4 differentially expressed proteins involved in the pathological process of esophageal cancer, such as annexinA1 (ANXA1), peroxiredoxin-2 (PRDX2), transgelin (TAGLN) andactin-aortic smooth muscle (ACTA2). 28392898 2017
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms 		0.330 Biomarker group CTD_human Comparative proteomic analysis of esophageal squamous cell carcinoma. 15986332 2005